4 free views remaining today

congenital myasthenic syndrome 15

Description

Congenital Myasthenic Syndrome (CMS) Description

Congenital myasthenic syndrome is a group of inherited conditions that are present from birth or early childhood. The condition is characterized by muscle weakness (myasthenia) that worsens with physical exertion.

  • Muscle Weakness: Muscle weakness is the primary symptom of CMS, which can range from mild to severe.
  • Age of Onset: The age of onset varies, but symptoms typically begin in early childhood or adolescence.
  • Facial and Eye Muscles Affected: Facial muscles, including those that control eyelid movement, and eye muscles are often affected.

The severity of CMS symptoms can vary greatly, from minor weakness to life-threatening breathing difficulties. In some cases, the condition may have little effect on daily life, while in others, it can significantly impact quality of life.

References:

  • [1] Congenital myasthenic syndromes are typically identified at birth. But if signs and symptoms are mild, the condition may not be identified until childhood, or rarely, early adulthood.
  • [6] Congenital myasthenic syndrome (CMS) is a group of inherited conditions that are present from birth or early childhood.
  • [11] Congenital myasthenic syndromes (CMS) are a group of genetic conditions that all include muscle weakness that gets worse with physical activity.

Signs and Symptoms

Muscle Weakness and Fatigue

The signs and symptoms of congenital myasthenic syndrome (CMS) vary based on the type, but common manifestations include muscle weakness and fatigue triggered by physical activity. This can range from mild to severe, with some individuals experiencing life-threatening symptoms like breathing difficulties.

  • Muscle fatigue and weakness triggered by physical activity [1]
  • Congenital myasthenic syndrome symptoms range from mild to severe [1]
  • Breathing difficulties in severe cases [1]

Additional Symptoms

In addition to muscle weakness, other symptoms of CMS may include:

  • Lack of muscle control in infants
  • Delayed development of motor skills like crawling or walking
  • Feeding difficulties due to muscle weakness
  • Stiff joints and feeding/breathing difficulties in infancy
  • Hanging eyelids (ptosis) and oculoparesis [9]
  • Variable but frequently moderate to severe limb muscle weakness [8]

Age-Related Symptoms

The age at which symptoms appear can also impact the severity of CMS. In general, the earlier the symptoms appear, the more pronounced the disease is.

  • Congenital myasthenic syndromes usually have a congenital onset, but the disease can manifest in children and even in adults [4]
  • Symptoms may be mild if they appear later in life, but sudden severe exacerbations of weakness are possible [13]

Presynaptic Symptoms

In some subtypes of CMS, presynaptic symptoms like brief stops in breathing, weakness of the eye, mouth, and throat muscles can occur. These symptoms often result in double vision and difficulty chewing and swallowing.

  • Brief stops in breathing and weakness of the eye, mouth, and throat muscles [14]

It's essential to note that the severity and type of symptoms can vary greatly among individuals with CMS. If you suspect a congenital myasthenic syndrome, it's crucial to consult a doctor for proper diagnosis and care.

References: [1] - Congenital myasthenic syndromes (CMS) are typically identified at birth. But if signs and symptoms are mild, the condition may not be identified until childhood, or rarely, early adulthood. [4] - Signs & Symptoms [8] - by AG Engel · 2015 · Cited by 549 — Nearly all patients have eyelid ptosis, oculoparesis that is often severe, and limb muscle weakness. [9] - In infancy, signs and symptoms include floppiness, a weak suck and cry, choking spells, stiff joints, feeding and breathing difficulties and hanging eye lids (ptosis) [13] - An individual with a congenital myasthenic syndrome (CMS) typically presents with a history of fatigable weakness involving ocular, bulbar, and limb muscles with onset at or shortly after birth or in early childhood, usually in the first two years. [14] - Congenital myasthenic syndrome (CMS) is an inherited neuromuscular disorder caused by defects of several types at the neuromuscular junction.

Additional Symptoms

  • Muscle fatigue and weakness triggered by physical activity
  • Congenital myasthenic syndrome symptoms range from mild to severe
  • Breathing difficulties in severe cases
  • Lack of muscle control in infants
  • Delayed development of motor skills like crawling or walking
  • Feeding difficulties due to muscle weakness
  • breathing difficulties in infancy
  • Variable but frequently moderate to severe limb muscle weakness
  • Brief stops in breathing, weakness of the eye, mouth, and throat muscles
  • ptosis

Diagnostic Tests

Diagnostic Tests for Congenital Myasthenic Syndrome

Diagnosing congenital myasthenic syndrome (CMS) requires a combination of clinical evaluation, physical examination, and various diagnostic tests. Here are some of the key tests used to diagnose CMS:

  • Physical Examination: A thorough physical examination is essential to identify signs of muscle weakness, fatigue, and other symptoms associated with CMS.
  • Electromyography (EMG): EMG measures the electrical activity of muscles and can help detect abnormalities in muscle function. [1]
  • Nerve Conduction Studies: These tests measure the speed and strength of nerve impulses and can help identify problems with nerve-muscle communication. [2]
  • Genetic Testing: Genetic testing can be used to identify specific genetic mutations associated with CMS. This is particularly useful for families with a history of the condition. [3][4]
  • Muscle Biopsy: A muscle biopsy involves taking a small sample of muscle tissue, which can be examined under a microscope to look for signs of muscle damage or abnormality. [5]

Additional Tests

Other tests that may be used to diagnose CMS include:

  • Electrophysiology studies: These tests measure the electrical activity of muscles and nerves.
  • Imaging studies: Such as MRI or CT scans, which can help identify any structural abnormalities in the brain or spinal cord.

It's worth noting that a definitive diagnosis of CMS often requires a combination of these tests, along with a thorough clinical evaluation. [6][7]

References:

[1] Search result 3: "A specialist needs to make a clinical diagnosis and carry out tests for Congenital myasthenic syndrome (CMS), which will include taking a clinical history and measuring the function and response of muscles and nerves to repeated stimulation."

[2] Search result 6: "Mayo Clinic doctors offer a wide range of tests to diagnose congenital myasthenic syndromes, including electromyography (EMG), nerve conduction studies..."

[3] Search result 7: "This test utilizes next-generation sequencing to detect single nucleotide and copy number variants in 28 genes associated with congenital myasthenic syndromes."

[4] Search result 8: "The Invitae Congenital Myasthenic Syndrome Panel analyzes genes associated with congenital myasthenic syndrome (CMS), a heterogeneous group of neuromuscular..."

[5] Search result 13: "Introduction The congenital myasthenic syndromes (CMS) are a group of inherited disorders in which neuromuscular transmission is impaired at the motor endplate..."

[6] Search result 10: "An individual with a congenital myasthenic syndrome (CMS) typically presents with a history of fatigable weakness involving ocular, bulbar, and limb muscles with onset at or shortly after birth or in early childhood..."

Treatment

Treatment Options for Congenital Myasthenic Syndrome (CMS)

Congenital Myasthenic Syndrome (CMS) is a rare genetic disorder that affects the nerve-muscle connection, leading to muscle weakness and fatigue. While there is no cure for CMS, various drug treatments can help manage symptoms and improve quality of life.

Cholinergic Agents

  • Cholinesterase inhibitors, such as pyridostigmine, are commonly used to treat CMS [5].
  • These medications work by increasing the amount of acetylcholine (ACh) available at the nerve-muscle junction, thereby improving muscle strength and function [6].

β-Adrenergic Agonists

  • Medications like salbutamol and ephedrine can be used as first-line treatments for CMS, particularly in cases where cholinesterase inhibitors are not effective [3].
  • These drugs work by stimulating the β-adrenergic receptors on muscle cells, leading to increased muscle strength and endurance [7].

Open-Channel Blockers

  • Quinidine and fluoxetine are examples of open-channel blockers that can be used in CMS treatment [6].
  • These medications work by blocking the acetylcholine receptor (AChR) at the nerve-muscle junction, thereby reducing muscle weakness and fatigue [8].

Other Treatment Options

  • 3,4-Diaminopyridine (3,4-DAP), also known as amifampridine, has been used to treat CMS in some cases [1].
  • Albuterol and ephedrine have also been reported to be effective in treating CMS, although more research is needed to confirm their efficacy [2].

Important Considerations

  • Certain medications, such as antibiotics, cardiovascular drugs, and psychiatric medications, should be avoided by individuals with CMS due to potential interactions or adverse effects [8].
  • It's essential for patients with CMS to work closely with their healthcare providers to develop a personalized treatment plan that takes into account their specific needs and medical history.

References:

[1] Context result 1 [2] Context result 2 [3] Context result 3 [5] Context result 5 [6] Context result 6 [7] Context result 7 [8] Context result 8

Recommended Medications

  • Cholinesterase inhibitors
  • β-Adrenergic Agonists
  • Open-Channel Blockers
  • 3,4-Diaminopyridine (3,4-DAP)
  • Albuterol and ephedrine

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0110658
core#notation
DOID:0110658
oboInOwl#hasDbXref
MIM:616227
IAO_0000115
A congenital myasthenic syndrome characterized by onset of progressive fatigable proximal muscle weakness in childhood that has_material_basis_in compound heterozygous mutation in the ALG14 gene on chromosome 1p21.
oboInOwl#hasExactSynonym
congenital myasthenic syndrome 15 without tubular aggregates
rdf-schema#label
congenital myasthenic syndrome 15
rdf-schema#subClassOf
t370528
RO_0002452
http://purl.obolibrary.org/obo/SYMP_0000094
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
RO_0004019
http://purl.obolibrary.org/obo/HP_0001197
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5009
owl#annotatedSource
t370429

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.